Annual Accounts Payable
$45.60 K
-$114.30 K-71.48%
March 1, 2024
Summary
- As of February 22, 2025, VRAX annual accounts payable is $45.60 thousand, with the most recent change of -$114.30 thousand (-71.48%) on March 1, 2024.
- During the last 3 years, VRAX annual accounts payable has fallen by -$171.50 thousand (-79.00%).
- VRAX annual accounts payable is now -94.61% below its all-time high of $846.50 thousand, reached on March 31, 2022.
Performance
VRAX Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$118.90 K
+$73.30 K+160.75%
September 1, 2024
Summary
- As of February 22, 2025, VRAX quarterly accounts payable is $118.90 thousand, with the most recent change of +$73.30 thousand (+160.75%) on September 1, 2024.
- Over the past year, VRAX quarterly accounts payable has dropped by -$289.70 thousand (-70.90%).
- VRAX quarterly accounts payable is now -85.95% below its all-time high of $846.50 thousand, reached on March 31, 2022.
Performance
VRAX Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
VRAX Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -71.5% | -70.9% |
| 3 y3 years | -79.0% | -49.8% |
| 5 y5 years | -78.6% | -45.2% |
VRAX Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -94.6% | at low | -86.0% | +160.8% |
| 5 y | 5-year | -94.6% | at low | -86.0% | +160.8% |
| alltime | all time | -94.6% | at low | -86.0% | +160.8% |
Virax Biolabs Group Limited Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $118.90 K(+160.7%) |
| Mar 2024 | $45.60 K(-71.5%) | $45.60 K(-88.8%) |
| Sep 2023 | - | $408.60 K(+155.5%) |
| Mar 2023 | $159.90 K | $159.90 K(-62.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $427.50 K(-49.5%) |
| Mar 2022 | $846.50 K(+289.9%) | $846.50 K(+257.8%) |
| Sep 2021 | - | $236.60 K(+9.0%) |
| Mar 2021 | $217.10 K(+2.0%) | $217.10 K |
| Mar 2020 | $212.80 K | - |
FAQ
- What is Virax Biolabs Group Limited annual accounts payable?
- What is the all time high annual accounts payable for Virax Biolabs Group Limited?
- What is Virax Biolabs Group Limited annual accounts payable year-on-year change?
- What is Virax Biolabs Group Limited quarterly accounts payable?
- What is the all time high quarterly accounts payable for Virax Biolabs Group Limited?
- What is Virax Biolabs Group Limited quarterly accounts payable year-on-year change?
What is Virax Biolabs Group Limited annual accounts payable?
The current annual accounts payable of VRAX is $45.60 K
What is the all time high annual accounts payable for Virax Biolabs Group Limited?
Virax Biolabs Group Limited all-time high annual accounts payable is $846.50 K
What is Virax Biolabs Group Limited annual accounts payable year-on-year change?
Over the past year, VRAX annual accounts payable has changed by -$114.30 K (-71.48%)
What is Virax Biolabs Group Limited quarterly accounts payable?
The current quarterly accounts payable of VRAX is $118.90 K
What is the all time high quarterly accounts payable for Virax Biolabs Group Limited?
Virax Biolabs Group Limited all-time high quarterly accounts payable is $846.50 K
What is Virax Biolabs Group Limited quarterly accounts payable year-on-year change?
Over the past year, VRAX quarterly accounts payable has changed by -$289.70 K (-70.90%)